产品名称
DSPE-PEG (2000) 羧酸, Avanti Research™ - A Croda Brand 880135P, powder
SMILES string
[H][C@@](COP([O-])(OCCNC(C/C=C\OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOCCOOCC(O)=O)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (880135P-10mg)
pkg of 1 × 100 mg (880135P-100mg)
pkg of 1 × 25 mg (880135P-25mg)
pkg of 1 × 50 mg (880135P-50mg)
pkg of 1 × 500 mg (880135P-500mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 880135P
shipped in
dry ice
storage temp.
−20°C
Application
DSPE-PEG（2000）羧酸用于：
- 将整联蛋白 α-2（ITGA2）抗体共价结合至脂质体表面
- 制备阿托西班结合的脂质体
- 制备双重互补脂质体
Biochem/physiol Actions
DSPE-PEG（2000）羧酸增加脂质体的血液循环时间。DSPE-PEG（2000）羧酸的羧基有助于和抗体共价结合。
General description
羧酸易溶于水和乙醇等极性溶剂。DSPE-PEG（2000）羧酸由2kDa的亲水性聚乙二醇（PEG）链组成。
Packaging
20 mL 透明玻璃螺旋盖小瓶 (880135P-500 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-10 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-100 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-25 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-50 mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
No data available
flash_point_c
No data available
Carboxylic Acid: Key Role in Life Sciences (2019)
Mohammad Mashreghi et al.
Nanoscale research letters, 15(1), 101-101 (2020-05-10)
In this study, we have surface-functionalized PEGylated-nanoliposomal doxorubicin (DOX) with anti-EpCAM (epithelial cell adhesion molecule) aptamer via post-insertion of anti-EpCAM aptamer-conjugated DSPE-mPEG2000 into Caelyx® (ED-lip). The size, charge, release profile, and cytotoxicity and cellular uptake of formulation were determined. The
ITGA2 as a potential nanotherapeutic target for glioblastoma
Guo P, et al.
Scientific reports, 9(1), 6195-6195 (2019)
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Guo P, et al.
Science advances, 5(3), eaav5010-eaav5010 (2019)
Junxue An et al.
Journal of colloid and interface science, 577, 92-100 (2020-05-31)
Phospholipids constitute biocompatible and safe excipients for pulmonary drug delivery. They can retard the drug release and, when PEGylated, also prolong the residence time in the lung. The aim of this work was to assess the structure and coherence of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持